Tissue factor (TF), apart from activating the extrinsic pathway of the blood coagulation, is a principal regulator of embryonic and oncogenic angiogenesis, inflammation, leukocyte reverse transmigration, and tumor progression. It has become clear that these events are mediated by intracellular signal transduction elicited by TF/factor VIIa (FVIIa) interaction, but the details of this signaling remain largely obscure. In this study, we show that FVIIa/TF-interaction produces STAT5 phosphorylation, STAT5 nuclear translocation and transactivation of a STAT5 reporter construct. FVIIa-dependent STAT5 activation was dependent on FVIIa proteolytic activity but not on generation of the downstream coagulation factors Xa and thrombin, nor on the TF cytoplasmic domain. FVIIa-induced STAT5 phosphorylation was dependent on functional G 12 /G 13 class G proteins and Jak2 activity, but not Jak1 or Tyk2. Finally, we show that FVIIa leads to cell survival through a Jak2/STAT5-dependent production of the antiapoptotic STAT5 target Bcl XL as well as Jak2-dependent activation of the antiapoptotic protein PKB. In conclusion, our results show that FVIIa induces cell survival through STAT5-dependent Bcl XL production and Jak2-dependent activation of PKB. Finally, we demonstrated for the first time that TF/FVIIa-signal transduction is dependent on G 12 /G 13 class G proteins. (Circ Res. 2004;94:1032-1040.)
T issue factor (TF) is the main initiator of the coagulation cascade. On vessel rupture, this transmembrane protein, normally not present on cells that are in contact with the bloodstream, binds with high affinity to the zymogen factor VII (FVII). The subsequent generation of factor Xa, thrombin, and fibrin deposition finally results in the formation of a blood clot. 1 In addition, a large variety of coagulationindependent functions for FVIIa/TF have been described. TF is absolutely required for embryonic blood vessel formation, because TF knockout mice are not viable due to an underdeveloped vascular system. 2 Furthermore, both TF and its ligand FVIIa have been shown to play a role in tumor metastasis, whereas TF has been shown to be an independent risk factor for hepatic metastasis in patients suffering from colon cancer. [3] [4] [5] Finally, the TF:FVIIa complex plays a role in sepsis and inflammation, because inhibition of this complex inhibits sepsis-induced mortality. 6, 7 It is generally accepted that TF:FVIIa interactions provokes intracellular signal transduction in TF-expressing cells. Among the cellular signaling cascades targeted by this interaction are the MAP kinase pathway, the PI3 kinase pathway, Ca 2ϩ signaling and activation of small GTPases, but such pathways are not a hallmark for inflammatory signaling per se. 8 -12 In 1990, Bazan noted the high homology between the extracellular part of TF and the proinflammatory interferon class II type receptors, including the interferon ␥ receptor. 13 Indeed, recent in silico analysis has shown that all current members of the cytokine receptor class II family are derived from an ancient TF gene, as TF is the only member of the protein family found in teleosts. 14 However, the intracellular part of TF does not resemble a cytokine receptor, and thus a cytokine receptor-like mechanism is unlikely. Rather, TF serves as a docking site for FVIIa, the latter cleaving a protease-activated receptor similar to the thrombin receptor thus triggering signal transduction. 15 Nevertheless, we explored the possibility of TF:FVIIa-induced activation of signal transduction that is normally associated with cytokine receptors, the Jak/STAT pathway.
We report that FVIIa induces STAT5 activation, subsequent nuclear translocation and transactivation of a STAT5dependent reporter construct, as well as production of the STAT5 target Bcl XL . This activation was dependent on FVIIa proteolytic activity, G 12 /G 13 GTPase activity, and Jak2, but not on the TF cytoplasmic tail. Finally, TF/FVIIa induced Jak2-dependent cell survival via activation of both STAT5 and PKB. Thus, our results show that FVIIa:TF complex formation results in activation of the Jak/STAT pathway. However, this pathway rather plays a role in FVIIa-induced cell survival than in inflammation. Thus, the activation of STAT transcription factors provides an obvious link between TF:FVIIa and their role in (patho)physiology along with cell survival and cancerous processes.
Materials and Methods

Materials
The antibodies raised against p-STAT5 (Tyr694), p-PKB, p-MAPK, and p-Tyk2 (Tyr1054/1055) were purchased from Cell Signaling Technologies. Antibodies against p-Jak1 (Tyr 1022/1023) and p-Jak2 (Tyr 1007/1008) were from Biosource, and antibodies against total Jak1 and 2 were from Upstate Biotech Inc. Antibodies against Tyk2 and Bcl XL were from Transduction Laboratories. Anti-FLAG and MTT were from Sigma. Total STAT 5 (directed against both A/B) G 12 and G 13 antibodies were from Santa Cruz. Recombinant FVIIa was purchased from Novo Nordisk, factor Xa was from Enzyme Laboratories, and thrombin was from Sigma. TAP was a kind gift from Dr G. Vlasuk (Corvas International, San Diego, Calif).
Constructs
Both of the DNA constructs encoding kinase-dead Jak1 and Jak2 were generous gifts from Dr David Levy (Department of Pathology, New York University School of Medicine, New York). The dominant-negative mutant of Jak1 contains a 3-amino acid change in the kinase domain (FWYAPE3 LTYAPV) and impairs its catalytic function. The dominant-negative mutant of JAK2 contains a single amino acid change (Lys3 Ala) at the ATP-binding site. The kinasedeleted Tyk2 construct was kindly provided by Dr Sandra Pellegrini (Unité de Biologie des Interactions Cellulaires, Institut Pasteur, Paris). This construct encodes a protein containing amino acids 1 to 895 of Tyk2. FLAG-tagged STAT5A and B were from Dr James Ihle (St Jude's Children's Hospital, Memphis, TN), G 12 and G 13 dominant-negative constructs (G 12 G228A) and (G 13 G225A) were from Dr Stefan Offermanns (Institute of Pharmacology, University of Heidelberg), and the STAT5-responsive NTCP-luciferase construct was provided by Mary Vore (Graduate Center of Toxicology, University of Kentucky). The dominant-negative pXM-STAT5A (truncated at residue 750) construct was obtained from Dr P. Coffer (Utrecht University), and this construct serves as an inhibitor to both STAT5A and STAT5B. 16 The insert was excised HindIII/XhoI and inserted into pcDNA3.1 (Invitrogen).
Cell Culture and Transfection
Baby hamster kidney cells, either stably transfected with full-length TF or with a TF cytoplasmic domain-deleted mutant truncated at residue 247 (all a generous gift from Dr L. Petersen, Novo Nordisk), were maintained in Dulbecco's Modified Eagle's Medium, supplemented with 10% fetal calf serum (FCS, Gibco) and penicillin/ streptomycin, at 37°C and 5% CO 2 in a humidified environment. 8, 17 Transient transfections were performed as follows: for FLAGtagged STAT5A, FLAG-tagged STAT5B or the luciferase expression constructs, cells were grown in 6-wells plates until 50% confluence and transfected with 0.4 g construct using 1.6 L Enhancer and 5 L Effectene transfection reagent (Qiagen). For transient transfections using dominant-negative constructs, 2.5 g construct, 21 g of Enhancer reagent, and 133 L of Effectene reagent were used. Using GFP-expression constructs, the transfection efficiency was determined to be at least 75%
Stable dominant-negative STAT5-expressing BHK TF cells were generated as follows: cells were grown in 6-wells plates until 50% confluence and transfected with 0.4 g pcDNA3.1, using Effectene reagent. Cells were grown in DMEM containing 700 g/mL G418, and positive clones were selected and screened for mutant STAT5 expression. Three clones (Nos. 1, 7, and 10) were selected for the experiments based on mutant STAT5 expression.
Immunoprecipitations
Treated cells were lysed in 0.5 mL lysis buffer (20 mmol/L Tris pH 7.5, 150 mmol/L NaCl, 1 mmol/L Na 2 EDTA, 1 mmol/L EGTA, 1% Triton X-100, 2.5 mmol/L sodium pyrophosphate, 1 mmol/L betaglycerophosphate, 1 mmol/L Na 3 VO 4 , and 1 g/mL leupeptin) and were collected by scraping. Subsequently, the lysate was centrifuged at 14 000 rpm for 2 minutes, and the supernatant was precleared with 20 L 50% protein A-Sepharose for 1 hour. The lysate was then incubated overnight with 1 g antibody. The immunocomplex was precipitated with 20 L 50% protein A-Sepharose for 1 hour. The Figure 1 . Proteolytically active FVIIa induces STAT5 activation via TF but not its cytoplasmic domain. A, BHK TF cells (black circles) or BHK TF⌬ cyto cells (white circles) were serum-starved and treated with 100 nmol/L FVIIa. BHK TF cells were also treated with 1 g/mL insulin for the times indicated (white squares). As a control, BHK cells were also stimulated with FVIIa (black squares). STAT5 phosphorylation was assessed, using phospho-STAT5 antibodies on Western blot and the protein bands were quantified. B, To test the necessity for proteolytic activity, BHK TF cells were also incubated with 100 nmol/L of an active siteblocked form of FVIIa (FVIIai). C, To test the potency of FVIIa-induced STAT5 phosphorylation, cells were subjected to various concentrations of FVIIa and STAT5 phosphorylation was assessed using Western blot. D, BHK TF cells were transfected with FLAG-tagged STAT5A (black circles) and FLAG-tagged STAT5B (white circles) constructs. After starvation, the cells were stimulated with 100 nmol/L FVIIa, and FLAG-tagged STAT5 was immunoprecipitated. Subsequently, the phosphorylation status of the immunoprecipitated STAT5 was assessed on Western blot, using a phosphospecific STAT5 antibody and bands were quantified.
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FVIIa-Induced Jak/STAT Activation beads were washed three times with lysis buffer and were subsequently resuspended in 40 L denaturing sample buffer (125 mmol/L Tris/HCl, pH 6.8; 4% SDS; 2% ␤-mercaptoethanol; 20% glycerol, 1 mg bromophenol blue).
Nuclear Isolation
Cell lysates were prepared and separated into nuclear and cytosolic fractions, as described before, 18 with some modifications; stimulated and washed cells (1 to 7ϫ10 6 ) were scraped in 200 L ice cold hypotonic lysis buffer (20 mmol/L HEPES, pH 7.9, 1.5 mmol/L MgCl 2 , 10 mmol/L KCl, 0.5 mmol/L dithiothreitol, 0.5 mmol/L pefabloc, and 0.5 g/mL of leupeptin and aprotinin). 19 The lysate was passed 10 times through a 27-gauche needle. After centrifugation at 600g, the resultant pellets (nuclear fraction) were washed again in lysis buffer and were resuspended in 300 L 1ϫ sample buffer. The supernatants (cytosolic fraction) were further diluted to 300 L with 3ϫ sample buffer.
Western Blotting
After treatment, cells were rapidly harvested by adding 100 L of heated (95°C) sample buffer and the lysates were collected by scraping. After 5 minutes of incubation at 95°C, 30 L of the lysates were loaded onto SDS-PAGE and subsequently transferred to a PVDF membrane. The membranes were blocked with Tris-buffered saline supplemented with 0.1% Tween (wash buffer) and 2% low-fat milk powder, and incubated with primary antibody overnight at 4°C, diluted 1:1000 in wash buffer containing 2.5% BSA. Subsequently, the membranes were incubated with a horseradish peroxidaseconjugated secondary antibody in wash buffer, containing 2% low-fat milk powder. The bands were visualized, using Lumilight plus ECL substrate from Roche and a chemiluminescence detector with a cooled CCD camera from Syngene.
Luciferase Assay
Cells were grown in 24-wells and transfected with either the STAT5-responsive construct NTCP-luciferase, or a CMV-driven luciferase construct for 16 hours. Transfections were performed as described above. After transfection, the cells were serum-starved for another 16 hours. Subsequently, cells were stimulated with 100 nmol/L FVIIa for 3 hours. Cells were lysed in 100 L luciferase assay buffer (25 mmol/L glycylglycine pH 7.9, 15 mmol/L MgSO 4 , 4 mmol/L EGTA, 1% Triton X-100, 1 mmol/L dithiothreitol) of which 50 L was used for the detection of luciferase activity on a Packard Topcount microplate scintillation counter.
Survival Assay
Cell viability was assessed using an MTT reduction assay (a colorimetric assay in which a tetrazolium compound is bioreduced by cells into a colored formazan product in direct proportion to the number of living cells in culture) in 24-well plates. Shortly, cells were starved for 1 day, after which FVIIa was added. Viability was measured at the times indicated in the graphs. The control was set at 100%.
Statistical Analysis and Quantification of the Western Blots
In all graphs, means and standard errors of at least triplicates are shown. When Western blots were analyzed for phosphorylation of STAT5, MAP kinase, or PKB, equal loading was determined by blotting for total protein as well. Antibody bands were quantified using Genetools from Syngene.
Results
FVIIa/TF Interaction Induces a Proteolytic Activity-Dependent, TF Cytoplasmic Tail-Independent Phosphorylation of STAT5
There is substantial sequence homology between the extracellular domains of TF and the interferon receptors. The intracellular domains of TF and the interferon receptors, however, are not much alike but an intriguing question remains whether TF together with its ligand, FVIIa, activates Jak/STAT pathways. Therefore, we set out to investigate the possible involvement of STATs in TF-dependent signal transduction and whether the intracellular tail is involved in such signaling. To this end, BHK cells either expressing full-length TF (BHK TF ) or a cytoplasmic domain deletion mutant (BHK TF⌬ cyto) were stimulated with recombinant FVIIa and STAT phosphorylation was determined using phosphospecific antibodies and Western blotting. 8, 17 We determined FVIIa-induced phosphorylation states of STAT1, STAT3, and STAT5. Although we did not observe FVIIainduced phosphorylation of STAT1 and STAT3 (results not shown), BHK TF cells reacted to FVIIa with a transient increase in phospho-STAT5 immunoreactivity, which was already detectable after 5 minutes, reached a maximum effect 10 minutes after stimulation and returned to basal levels after approximately 60 minutes, whereas pan-STAT5 immunoreactivity was not affected ( Figure 1A ). Importantly, BHK TF⌬ cyto cells responded to FVIIa stimulation with transient STAT5 phosphorylation indistinguishable of that observed in BHK cells transfected with full-length TF, and therefore, we concluded that cytoplasmic domain of TF is not involved in this phosphorylation. Interestingly, this FVIIainduced phosphorylation was much more transient than that observed after stimulation with insulin, an established inducer of STAT5 phosphorylation ( Figure 1A ). 19 We also assessed the importance of FVIIa proteolytic activity using active site-inhibited FVIIa (FFR-VIIa or FVIIai). We observed that although a 10-minute stimulation with FVIIa potently induced STAT5 activation, FVIIai was ineffective in this respect ( Figure 1B ). We concluded that the FVIIa-dependent STAT5 phosphorylation is mediated by the extracellular domain of TF and FVIIa proteolytic activity. Dose-response analysis of FVIIa-induced STAT5 phosphorylation revealed that enhanced STAT5 phosphorylation in response to this protease was already detectable at concentrations as low as 1 nmol/L ( Figure 1C ), lying well within the physiological ranges of FVII in plasma (10 nmol/L). Finally, we assessed which isoform of STAT5, STAT5A, or STAT5B is/are activated on FVIIa stimulation. To this end, we transiently transfected BHK TF with expression constructs encoding either FLAG-tagged STAT5A or FLAG-tagged STAT5B. 20 Subsequently, cells were stimulated with FVIIa for various times and FLAG-tagged STAT5 was immunoprecipitated using a FLAG antibody. Finally, phosphorylation of STAT5 was Figure 3 . FVIIa-induced STAT5 phosphorylation is dependent on G 12 /G 13 but not on G i . A, BHK TF cells were pretreated for 6 hours with 100 ng/mL pertussis toxin (PTX) and subsequently stimulated with LPA or FVIIa. MAP kinase phosphorylation or STAT5 phosphorylation was determined on Western blot. B, Cells were transiently transfected with dominant-negative G 12␣ -or G 13␣expressing constructs, subsequently serum-starved, and stimulated with 100 nmol/L FVIIa. Phosphorylated STAT5 as well as total levels of STAT5, G 12 , and G 13 were determined on Western blot. Figure 4 . Jak2, but not Jak1 or Tyk2, is required for FVIIa-induced STAT5 phosphorylation. A, BHK TF cells were stimulated for the indicated times with 100 nmol/L FVIIa. Subsequently, Jak1 (black circles), Jak2 (white circles), and Tyk2 (black squares) were analyzed for phosphorylation on Western blot and bands were quantified. B, In a similar experiment, phosphorylation of Jak1 (white bars), Jak2 (gray bars), and Tyk2 (black bars) was determined after 10 minutes of stimulation with the indicated FVIIa concentrations. C, BHK TF cells were transfected with kinase-dead Jak1, Jak2, and Tyk2 mutants, after which cells were starved and stimulated with 100 nmol/L FVIIa. Cell lysates were analyzed on Western blot for STAT5 phosphorylation, total amounts of STAT5, and total amounts of Jak kinases. D, Cells were preincubated with various concentrations of the specific Jak2 inhibitor AG490 and subsequently stimulated mock or with 100 nmol/L FVIIa. STAT5 phosphorylation as well as total amounts of this protein were determined by Western blot.
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FVIIa-Induced Jak/STAT Activation determined using a phosphospecific antibody for STAT5. We observed that, whereas total levels of FLAG-STAT5A and FLAG-STAT5B remained unchanged, the phosho-STAT5 immunoreactivity was transiently increased with respect to both STAT5A and STAT5B ( Figure 1D) , and hence, both STAT5 isoforms are a target for FVIIa-dependent signaling.
FVIIa-Induced STAT Phosphorylation Is not Dependent on Generation of Thrombin or FXa
After exposure of TF to the bloodstream, interaction of TF with FVII will take place, leading to FVII activation. The thus-generated FVIIa converts FX to FXa, and in turn, FXa activates thrombin. Hence, addition of FVIIa to cells may lead to FXa and thrombin generation. In order to investigate a possible role of FXa or thrombin in FVIIa-dependent STAT5 activation, we tested the effect of the FXa inhibitor TAP and the thrombin inhibitor hirudin on FVIIa-evoked STAT5 phosphorylation. As is obvious from Figure 2 , both FXa and thrombin are capable of inducing STAT5 phosphorylation, and the effects of FXa and thrombin are sensitive to 200 nmol/L of TAP and 25 U/mL of hirudin, respectively. These inhibitors, however, did not influence FVIIa-induced STAT5 phosphorylation (Figure 2 ). Thus, although multiple factors of the coagulation cascade have the capacity to activate STAT5, the FVIIa-mediated STAT5 phosphorylation does not rely on either FXa or thrombin generation.
FVIIa-Mediated STAT5 Phosphorylation Is Dependent on G 12 /G 13 , but not on G i Heterotrimeric G Proteins
FVIIa is believed to induce signaling through a protease-activated receptor (PAR), a heterotrimeric G protein-coupled receptor that has high homology with the thrombin receptor. However, until now, the nature of the G proteins involved is highly unclear. Therefore, we decided to investigate the involvement of two classes of G proteins that are frequently activated on thrombin stimulation; G i and G 12 /G 13 . To investigate the role of G i , BHK TF cells were preincubated for 6 hours with the G i inhibitor pertussis toxin (PTX). Whereas this toxin potently inhibited MAP kinase phosphorylation induced by lysophosphatidic acid (LPA), a well-known G i activator, PTX did not inhibit FVIIa-induced STAT5 phosphorylation ( Figure 3A ), ruling out a role for G i in FVIIainduced STAT5 phosphorylation. Next, we determined the influence of G 12 /G 13 in this system, through transient transfection of BHK TF cells with inactive G 12a or G 13␣ expression vectors. The transfection efficiency in our system was at least 75% as determined with GFP-expression constructs. As is clear from Figure 3B , both inactive G 12a or G 13␣ inhibited FVIIa-induced STAT5 phosphorylation. However, the use of dominant-negative G 12a or G 13␣ did not inhibit, but rather enhanced insulin-induced STAT5 phosphorylation. This demonstrates that functional G 12 and G 13 proteins are absolutely required for FVIIa-induced STAT5 phosphorylation.
FVIIa Induces STAT Phosphorylation via Activation of Jak2
The upstream kinases activating STATs are known as Jaks (Janus kinases) of which four forms exist: Jak1, Jak2, Jak3, and Tyk2. Using phosphospecific antibodies, the phosphorylation states of Jak1, Jak2, and Tyk2 were determined. Figure 4A shows that Jak1, Jak2, and Tyk2 phosphorylation are transiently upregulated after FVIIa stimulation. Whereas Jak2 and Tyk2 phosphorylation return to basal levels within 15 minutes, Jak1 phosphorylation was more persistent; phosphorylation was still observed after 45 minutes (not shown). Furthermore, phosphorylation of these kinases was already observed at FVIIa concentrations as low as 1 nmol/L ( Figure 4B ). To establish the nature of Janus kinases in the phosphorylation of STAT5, we explored the role of these kinases in Figure 5 . Jak2 activity is essential for FVIIa-induced PKB phosphorylation. BHK TF cells were starved and preincubated with the indicated concentrations of AG490. Subsequently, cells were left untreated (white bars) or treated with 100 nmol/L FVIIa (black bars), and phosphorylation levels of PKB (A) and MAP kinase (B) were determined on Western blot, using phosphospecific antibodies after which the bands were quantified. C, BHK TF cells were transiently transfected with a dominant-negative Jak2 construct, starved, and stimulated with FVIIa. Subsequently, phosphorylation levels of PKB (white bars) and MAP kinase (black bars) were determined on Western blot, using phosphospecific antibodies, and the bands were quantified.
this system by transiently transfecting BHK TF cells with DNA-constructs, encoding kinase-dead variants of Jak1, Jak2, and Tyk2. These proteins have previously been shown to potently inhibit endogenous Jak1, Jak2, and Tyk2 enzymatic activity. 21, 22 As can be seen in Figure 4C , transfection of cells with kinase-dead Jak2 abrogated FVIIa-induced STAT5 phosphorylation, whereas the use of a kinase-dead Jak1 or Tyk2 mutant did not have this effect. We also preincubated BHK TF cells with the specific Jak2 inhibitor AG490. As can be seen in Figure 4D , a 25 mol/L preincubation with this inhibitor abrogates FVIIa-induced STAT5 phosphorylation. We concluded that, although FVIIa induces activation of Jak1, Jak2, and Tyk2, only Jak2 is essential in FVIIa-dependent STAT5 phosphorylation.
Jak2 Activity Is Essential for FVIIa-Induced PKB Phosphorylation
To check whether the effects of the Jak2 inhibitor AG490 on STAT5 phosphorylation were specific, the effect of AG490 incubation on other FVIIa targets such as MAP kinase and the anti-apoptotic protein PKB was also investigated. AG490 incubation showed no effect on MAP kinase phosphorylation ( Figure 5A) ; however, it did inhibit PKB phosphorylation ( Figure 5B ). Transfection of BHK TF cells with dominant-negative Jak2 showed similar effects (Figure 5C ), pointing out a role for Jak2 in FVIIa-induced PKB activation.
FVIIa Induces STAT5 Translocation and Transactivation
STAT5 translocation to the nucleus is essential for STAT5 function, and thus if FVIIa-dependent STAT5 phosphorylation is relevant, it should result in such a translocation. Hence, BHK TF were subjected to FVIIa for various times, and subsequently, cell fractionation was used to produce nucleusenriched and cytosol-enriched fractions. FVIIa treatment produced a marked increase in STAT5 phosphorylation in both the cytosolic and the nuclear fraction ( Figure 6A ) that was observed at concentrations as low as 1 nmol/L ( Figure  6B ). Strikingly, STAT5 phosphorylation in the cytosol was enhanced compared with STAT5 phosphorylation in the nucleus. The latter might be due to the presence of nuclearlocalized STAT phosphatases, such as TC-PTP, which have been shown to dephosphorylate STAT5 in the nucleus. 23 To further establish the relevance of FVIIa-induced STAT5 phosphorylation, we made use of a STAT5-responsive luciferase reporter construct. Cells were transfected with either this construct or a constitutive luciferase-expressing construct. After starvation, cells were stimulated with 100 nmol/L FVIIa for 3 hours, and luciferase activity was determined. Figure 6C shows that a 3-hour treatment with FVIIa strongly enhances luciferase activity. Thus, FVIIa provokes Jak2-dependent STAT5 phosphorylation, nuclear translocation, and transactivation.
FVIIa Induces Jak2/STAT5-Dependent Expression of Bcl XL
Bcl XL is an antiapoptotic protein that has been shown to be upregulated as a result of STAT5 activation. 24, 25 Because FVIIa in our systems activates STAT5, we decided to investigate FVIIa-induced Bcl XL expression. Therefore, we starved BHK TF cells for 2 hours and stimulated them with 100 nmol/L of FVIIa. As can be seen in Figure 7A , stimulation of these cells results in an increase in Bcl XL in time that showed to be concentration-dependent ( Figure 7B ). This expression could not be reversed with 10 mol/L of AG490, but Bcl XL Figure 6 . FVIIa stimulates STAT5 translocation to the nucleus and STAT5dependent gene transcription. A, Cells were starved and stimulated with 100 nmol/L FVIIa for various times. Subsequently, cells were fractionated into cytosolic (black circles) and nuclear fractions (white circles); these fractions were analyzed for phosphorylated STAT5 contents by Western blot, and the bands were quantified. Total ␤-actin contents were also determined as a measure for the purity of the fractions. B, Nuclear translocation was also determined in cells that were stimulated with the indicated concentrations of FVIIa. C, Cells were transfected with NTCP-luciferase or CMVluciferase. After serum starvation, cells were stimulated with FVIIa for 3 hours, and luciferase activity was determined. To exclude aspecific signals, the normalized luciferase activity was obtained by dividing the signal from cells transfected with NTCP-luciferase, by the signal obtained from cells transfected with CMV-luciferase.
expression could be inhibited with the same concentration of Jak2 inhibitor (25 mol/L) that also potently inhibited STAT5 phosphorylation ( Figure 7C) .
To investigate the role of STAT5 in FVIIa-induced BclXL expression, we constructed BHK TF cells stably expressing dominant-negative STAT5 ( Figure 7D ). Whereas wild-type cells considerably upregulate Bcl XL after FVIIa stimulation, dominant-negative STAT5-expressing cells show only a moderate upregulation of Bcl XL (Figure 7E ), whereas activation of FVIIa targets such as MAP kinase, PKB, and Jak2 were not affected ( Figure 7F ). Therefore, we concluded that FVIIa-induced Bcl XL expression is mediated, at least partially, via STAT5.
Jak2/STAT5 Are Involved in FVIIa-Induced Cell Survival
Because Jak2 and STAT5 were shown to be involved in FVIIa-driven Bcl XL expression and Jak2 activity was shown to be essential for PKB phosphorylation in BHK TF cells, we decided to investigate the role of Jak2 and STAT5 in FVIIa-induced cell survival, a recently described phenomenon. 26, 27 Therefore, cells were starved and preincubated with 10 mol/L and 25 mol/L AG490 before stimulation with FVIIa. FVIIa (100 nmol/L) efficiently promoted cell survival in serum-starved cells ( Figure 8A ) and 10 mol/L of AG490 did not inhibit this effect. However, 25 mol/L of AG490, the same concentration that efficiently inhibited STAT5 phosphorylation and Bcl XL expression, also inhibited FVIIainduced survival. Finally, to address the role of STAT5, wild-type BHK TF cells and STAT5 mutant cells were starved and incubated with FVIIa. Whereas wild-type cells show a considerable survival after 1 and 2 days of FVIIa stimulation, STAT5 mutant cells show a greatly diminished cell survival ( Figure 8B ). Therefore, we conclude that FVIIa induces cell survival via Jak2 and STAT5 activation.
Discussion
It is now generally recognized that TF, apart from its role in coagulation, is an important mediator in inflammation and cancerous processes. [3] [4] [5] [6] [7] The molecular basis, however, of this action remains unclear. In the present report, we provide evidence that FVIIa provokes Jak2-dependent phosphorylation of STAT5 via G 12 /G 13 , followed by nuclear translocation and transactivation by this transcription factor. Furthermore, Figure 7 . FVIIa induces Jak2-and STAT5-dependent Bcl XL expression. A, Cells were serum-starved for 1 hour and subsequently stimulated mock (white circles) or with 100 nmol/L FVIIa (black circles) for the times indicated. Bcl XL expression was assayed on Western blot and quantified. B, Cells were starved for 1 hour and stimulated with the indicated concentrations of FVIIa. Bcl XL expression was determined on Western blot, and Bcl XL expression in unstimulated cells was set at 1. C, Cells were pretreated with AG490 for 16 hours and subsequently serum-starved. At tϭ0 hours, cells were stimulated mock (white bars) or with 100 nmol/L FVIIa (black bars) for 10 hours in the presence or absence of AG490; Bcl XL expression was determined on Western blot and expressed as percent of expression on tϭ0. D, BHK TF cells were stably transfected with dominant-negative STAT5 as described in the Materials and Methods section, and mutant STAT5 expression was assayed using Western blot. Clones were designated Nos. 1, 7, and 10. E, BHK TF (WT) and mutant STAT5 cells (⌬STAT5) were starved at day 0 and stimulated mock (white bars) or with FVIIa (black bars) for 24 hours. Bcl XL levels at day 0 and after 24 hours were determined on Western blot, and Bcl XL levels after 24 hours were expressed as percent of expression on day 0. F, BHK TF (white bars) and mutant STAT5 cells (black bars) were starved and stimulated mock or with FVIIa for 10 minutes. Phosphorylation of the indicated kinases was determined on Western blot and quantified; unstimulated phosphorylation levels were set at 1.
we show that Jak2 and STAT5 are involved in FVIIa-driven Bcl XL expression and cell survival.
We showed that STAT5 phosphorylation is independent of the TF cytoplasmic tail, but relies on the proteolytic activity of FVIIa. These data are most consistent with the oftenproposed platform hypothesis, in which TF serves as a docking site for FVIIa, which in turn proteolytically cleaves and thereby activates a protease-activated G protein-coupled receptor. One of the proteins that has frequently been implicated in FVIIa:TF-dependent signaling is protease-activated receptor 2 (PAR-2), 15 although involvement of any of the known PARs in BHK TF has been excluded. 28 A transient phosphorylation of STAT5 coinciding with activation of Jak1, Jak2, and Tyk2 was observed. Although only functional Jak2 was required for STAT5 responses, other Janus kinases may have downstream targets such as other members of the STAT family of signal transducers, but obviously further work is needed to substantiate this notion.
We were able to show that FVIIa upregulated the STAT5 target Bcl XL , suggesting a role for FVIIa-induced STAT5 phosphorylation in the prevention from apoptosis. Such a role has indeed been shown by ourselves and others, and could form an explanation for the role of TF and FVIIa in tumor growth and metastasis. [3] [4] [5] 26, 27 Indeed, also in this article, we show that FVIIa induces survival in cells that are stimulated to go into apoptosis, but this survival was inhibited by the Jak2 inhibitor AG490 or expression of dominant-negative STAT5. Moreover, Jak2 activity in our system proved essential for activation of the antiapoptotic kinase PKB, the latter being a key player in FVIIa-induced cell survival. 26, 27 Indeed, Jak2 has been found to be an upstream activator of PKB before. 29 Therefore, we hypothesize that Jak2 exerts its antiapoptotic effects through activation of both STAT5 and PKB, thus positively influencing tumor growth and possibly metastasis. Currently, it is unknown whether Jak2 influences PKB activity directly, or via PKB's upstream kinase PI-3 kinase, but previous work suggests that PI-3 kinase may be an intermediate in Jak2-dependent PKB activation. 10, 11 Induction of STAT5, Jak1, and Jak2 phosphorylation was already observed at concentrations as low as 1 nmol/L. Because plasma levels of FVII are normally maintained at 10 nmol/L, this concentration of FVIIa appears to be physiologically relevant. FVIIa-induced activation of proteins such as c-Akt/PKB occurs at slightly higher concentrations (10 nmol/ L), suggesting that FVIIa-induced STAT5 phosphorylation is a relatively efficient process. It is possible that this difference might be due to activation of different G proteins coupling to the FVIIa proteolytic target. We indeed show for the first time that FVIIa-induced Jak2/STAT5 activation occurs via the heterotrimeric G proteins G 12 /G 13 , whereas G i played no role. Both the G 12 /G 13 and G i classes of G proteins were investigated because these signal transducers are also frequently activated by thrombin. A third class of G proteins, also activated by thrombin is G q . Activation of the latter G protein leads to transient calcium release and subsequent calciumdependent signal transduction. However, in contrast to thrombin, FVIIa does not elicit calcium signals in BHK TF cells, ruling out G q activation. 28 In conclusion, FVIIa induces activation of the Jak/STAT pathway via G proteins, leading to enhanced cell survival. Figure 8 . FVIIa induces Jak2-and STAT5-dependent cell survival. A, BHK TF cells were pretreated with AG490 at the indicated concentrations and starved for 16 hours. Subsequently, cells were treated mock (white bars) or with 100 nmol/L FVIIa (black bars). At day 1, survival was assessed using an MTT assay. Viability was expressed as percent of cell viability at day 0. B, BHK TF (WT) and mutant STAT5 cells (⌬STAT5) were starved at day 0 in stimulated mock (white bars) or with 100 nmol/L FVIIa (black bars). Viability was monitored at day 0, 1, and 2, and viability was expressed as a percent of the viability at day 0.
